XML 65 R48.htm IDEA: XBRL DOCUMENT v3.20.4
Quarterly Information (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2020
Quarterly Financial Information Disclosure [Abstract]  
Schedule of Quarterly Financial Information The tables below present summarized unaudited quarterly results of operations for the years ended December 31, 2020 and 2019.

 

 

Quarter Ended

 

 

 

 

March 31,

 

 

June 30,

 

 

September 30,

 

 

December 31,

 

 

 

 

(In thousands except per share amounts)

 

 

2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

509,217

 

 

$

491,475

 

 

$

547,961

 

 

$

541,276

 

 

Income from continuing operations, net of taxes

 

$

21,251

 

 

$

30,721

 

 

$

45,063

 

 

$

46,156

 

 

Income (loss) from discontinued operations, net of taxes

 

$

12,816

 

 

$

10,993

 

 

$

(7,502

)

 

$

(828,697

)

(1)

Net income (loss) attributable to Acadia

   Healthcare Company, Inc. stockholders

 

$

33,463

 

 

$

41,079

 

 

$

36,998

 

 

$

(783,672

)

(1)

Basic earnings per share attributable to Acadia

  Healthcare Company, Inc. stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from continuing operations attributable to

   Acadia Healthcare Company, Inc.

 

$

0.24

 

 

$

0.34

 

 

$

0.51

 

 

$

0.51

 

 

Income (loss) from discontinued operations

 

$

0.14

 

 

$

0.13

 

 

$

(0.09

)

 

$

(9.42

)

(1)

Net (loss) income attributable to Acadia Healthcare

   Company, Inc.

 

$

0.38

 

 

$

0.47

 

 

$

0.42

 

 

$

(8.91

)

(1)

Diluted earnings per share attributable to Acadia

  Healthcare Company, Inc. stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from continuing operations attributable to

   Acadia Healthcare Company, Inc.

 

$

0.23

 

 

$

0.34

 

 

$

0.50

 

 

$

0.50

 

 

Income (loss) from discontinued operations

 

$

0.15

 

 

$

0.12

 

 

$

(0.08

)

 

$

(9.28

)

(1)

Net (loss) income attributable to Acadia Healthcare

   Company, Inc.

 

$

0.38

 

 

$

0.46

 

 

$

0.42

 

 

$

(8.78

)

(1)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2019:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Revenue

 

$

487,960

 

 

$

509,813

 

 

$

509,383

 

 

$

501,225

 

 

Income (loss) from continuing operations, net of taxes

 

$

13,618

 

 

$

26,964

 

 

$

24,920

 

 

$

(12,192

)

(2)

Income from discontinued operations, net of taxes

 

$

15,893

 

 

$

21,237

 

 

$

17,803

 

 

$

1,879

 

(2)

Net income (loss) attributable to Acadia

  Healthcare Company, Inc. stockholders

 

$

29,471

 

 

$

48,140

 

 

$

42,566

 

 

$

(11,254

)

(2)

Basic earnings per share attributable to Acadia

   Healthcare Company, Inc. stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations attributable to Acadia Healthcare Company, Inc.

 

$

0.16

 

 

$

0.31

 

 

$

0.28

 

 

$

(0.15

)

(2)

Income from discontinued operations

 

$

0.18

 

 

$

0.24

 

 

$

0.21

 

 

$

0.02

 

(2)

Net income (loss) attributable to Acadia Healthcare

   Company, Inc.

 

$

0.34

 

 

$

0.55

 

 

$

0.49

 

 

$

(0.13

)

(2)

Diluted earnings per share attributable to Acadia

  Healthcare Company, Inc. stockholders:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income (loss) from continuing operations attributable to Acadia Healthcare Company, Inc.

 

$

0.15

 

 

$

0.31

 

 

$

0.28

 

 

$

(0.15

)

(2)

Income from discontinued operations

 

$

0.19

 

 

$

0.24

 

 

$

0.20

 

 

$

0.02

 

(2)

Net income (loss) attributable to Acadia Healthcare

   Company, Inc.

 

$

0.34

 

 

$

0.55

 

 

$

0.48

 

 

$

(0.13

)

(2)

 

(1)

Includes U.K. loss on sale of $867.3 million which includes approximately $356.2 million of non-cash goodwill impairment.

(2)

Includes loss on impairment of $27.2 million in continuing operations and $27.2 million in discontinued operations.